Recital 1, Decision_act (EU) 2025/1805

In forcesince 11 Sep 2025

On 11 September 2017, ODYSSEE Environnement submitted an application to the European Chemicals Agency (‘the Agency’) in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013 [Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj).] for Union authorisation of the same biocidal product family, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013, named ‘ODYSSEE ENVIRONNEMENT CMIT/MIT biocidal product family’, of product-type 11, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-HR033845-20 in the Register for Biocidal Products. The application also indicated the case number of the related reference product family ‘LANXESS CMIT/MIT biocidal product family’, later authorised by Commission Implementing Regulation (EU) 2024/2750 [Commission Implementing Regulation (EU) 2024/2750 of 25 October 2024 granting a Union authorisation for the biocidal product family ‘LANXESS CMIT/MIT biocidal product family’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/2750, 28.10.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2750/oj).], with authorisation number EU-0031652-0000.